Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis
Open Access
- 1 January 2012
- journal article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 14 (1), R32
- https://doi.org/10.1186/ar3736
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Is there a feudal hierarchy amongst regulatory immune cells? More than just TregsArthritis Research & Therapy, 2009
- Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progressionJCI Insight, 2008
- Regulatory B cells as inhibitors of immune responses and inflammationImmunological Reviews, 2008
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory ResponsesImmunity, 2008
- The ‘short’ history of regulatory B cellsTrends in Immunology, 2008
- CD19 Expression in B Cells Is Important for Suppression of Contact HypersensitivityThe American Journal of Pathology, 2007
- Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cellsProceedings of the National Academy of Sciences, 2007
- Therapeutic actions of cyclosporine and anti-tumor necrosis factor ? in collagen-induced arthritis and the effect of combination therapyArthritis & Rheumatism, 1998
- Suppressive Role of B Cells in Chronic Colitis of T Cell Receptor α Mutant MiceThe Journal of Experimental Medicine, 1997
- Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.JCI Insight, 1996